Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

NCT04585893 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators